Clinical Trial Update: Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase trial evaluated the safety and potential activity of topical 5-fluorouracil and imiquimod in high-grade cervical intraepithelial neoplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Cervical Squamous Cell Carcinoma in Situ
• High-grade Cervical Intraepithelial Neoplasia

Drugs mentioned

• 5-fluorouracil (topical) (5-fluorouracil)
• Imiquimod (imiquimod)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Squamous Cell Carcinoma In Situ | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-02-23